CN105998299A - 应用于妇科的解毒敛湿的药物及其制备方法 - Google Patents
应用于妇科的解毒敛湿的药物及其制备方法 Download PDFInfo
- Publication number
- CN105998299A CN105998299A CN201610320957.3A CN201610320957A CN105998299A CN 105998299 A CN105998299 A CN 105998299A CN 201610320957 A CN201610320957 A CN 201610320957A CN 105998299 A CN105998299 A CN 105998299A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- prepares
- pill
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 230000000452 restraining effect Effects 0.000 title abstract 4
- 239000006187 pill Substances 0.000 claims abstract description 24
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 20
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 20
- 231100000614 poison Toxicity 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 239000003440 toxic substance Substances 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 17
- 238000003809 water extraction Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 10
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 5
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 5
- 240000004460 Tanacetum coccineum Species 0.000 claims description 5
- 235000008384 feverfew Nutrition 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 26
- 210000001215 vagina Anatomy 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 5
- 231100000419 toxicity Toxicity 0.000 abstract description 5
- 230000001988 toxicity Effects 0.000 abstract description 5
- 208000003251 Pruritus Diseases 0.000 abstract description 3
- 230000002175 menstrual effect Effects 0.000 abstract description 2
- 244000045947 parasite Species 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 6
- 206010046914 Vaginal infection Diseases 0.000 description 5
- 206010008323 cervicitis Diseases 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000006374 Uterine Cervicitis Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010068402 Cervix inflammation Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010028116 Mucosal inflammation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- DTGKSKDOIYIVQL-QXFUBDJGSA-N (-)-borneol Chemical compound C1C[C@]2(C)[C@H](O)C[C@H]1C2(C)C DTGKSKDOIYIVQL-QXFUBDJGSA-N 0.000 description 1
- 229930006703 (-)-borneol Natural products 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HJYUZIDYQOZTBZ-UHFFFAOYSA-J [K+].S(=O)(=O)([O-])[O-].[Al+3].NN.S(=O)(=O)([O-])[O-] Chemical compound [K+].S(=O)(=O)([O-])[O-].[Al+3].NN.S(=O)(=O)([O-])[O-] HJYUZIDYQOZTBZ-UHFFFAOYSA-J 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000010442 acute cervicitis Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052934 alunite Inorganic materials 0.000 description 1
- 239000010424 alunite Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 208000011404 female reproductive system disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000005125 simple columnar epithelium Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- KPZTWMNLAFDTGF-UHFFFAOYSA-D trialuminum;potassium;hexahydroxide;disulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O KPZTWMNLAFDTGF-UHFFFAOYSA-D 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
应用于妇科的解毒敛湿的药物,由下述重量比的原料制成:冰片0.1~4份,青黛0.2~10份,滑石粉1~15份,白矾0.3~15份,甘草1~17份,黄柏2~20份,金银花5~15份,连翘2~17份,其制备方法,包括丸剂的制备和水剂的制备,本发明具有杀菌抗虫、清热解毒、清热敛湿、止痛止痒、去除异味、止血通经的作用,对妇科疾病具有清热敛湿的效果,并且还能起到润泽紧致阴道的保健作用。
Description
技术领域
本发明涉及一种药物及其制备方法,具体是应用于妇科的解毒敛湿的药物及其制备方法。
背景技术
妇科炎症是女性生殖系统的疾病,主要症状是以白带增多为主,并伴有外阴不适及痒痛,中医称带下病。最常见的为阴道炎、宫颈炎,湿热毒带,多见于现代医学的盆腔炎,宫颈炎,宫颈糜烂,阴道炎等,多因湿热下注或热毒蕴结损伤任、带二脉所致。
正常健康妇女阴道由于解剖组织的特点对病原体的侵入有自然防御功能,如阴道口的闭合,阴道前后壁紧贴,阴道上皮细胞在雌激素的影响下的增生和表层细胞角化,阴道酸碱度保持平衡,使适应碱性的病原体的繁殖受到抑制,而颈管黏液呈碱性,当阴道的自然防御功能受到破坏时,病原体易于侵入,导致阴道炎症。
正常情况下有需氧菌及厌氧菌寄居在阴道内,形成正常的阴道菌群。任何原因将阴道与菌群之间的生态平衡打破,也可形成条件致病菌。临床上常见有:细菌性阴道病、念珠菌性阴道炎、滴虫性阴道炎、老年性阴道炎、幼女性阴道炎。
宫颈炎是妇科常见疾病之一,包括子宫颈阴道部炎症及子宫颈管黏膜炎症。因子宫颈管阴道部鳞状上皮与阴道鳞状相延续,阴道炎症均可引起子宫颈阴道部炎症。由于子宫颈管黏膜上皮为单层柱状上皮,抗感染能力较差,易发生感染。临床多见的子宫颈炎是急性子宫颈管黏膜炎,若急性子宫颈炎未经及时诊治或病原体持续存在,可导致慢性子宫颈炎症。
发明内容
本发明提供了应用于妇科的解毒敛湿的药物及其制备方法。
应用于妇科的解毒敛湿的药物,由下述重量比的原料制成:冰片0.1~4份,青黛0.2~10份,滑石粉1~15份,白矾0.3~15份,甘草1~17份,黄柏2~20份,金银花5~15份,连翘2~17份;
进一步优化,应用于妇科的解毒敛湿的药物,由下述重量比的原料制成:冰片1~3份,青黛3~7份,滑石粉5~10份,白矾1~10份,甘草5~12份,黄柏10~13份,金银花7~12份,连翘7~12份;
应用于妇科的解毒敛湿的药物,所述的冰片为菊科植物艾纳香的新鲜茎叶经提取加工制成的结晶;
应用于妇科的解毒敛湿的药物,所述的青黛、甘草、黄柏、金银花、连翘为干燥的药材;
丸剂的制备包括下述步骤:
(1)、称取各原料;
(2)、将步骤(1)称取的冰片、青黛、滑石粉、白矾、甘草制粉;
(3)、将步骤(2)制得的粉消毒灭菌,放置备用;
(4)、将步骤(1)称取的黄柏、金银花、连翘碎断,碎断的长度为5~10mm,用酒精提取,制得提取液,再将提取液浓缩至含生药1~2g/ml;
(5)、将步骤(4)产生的药渣用水提取,用水提取的温度为60~90度,制得提取液,再将提取液浓缩至含生药1~2g/ml;
(6)、将步骤(3)制得的粉剂与步骤(4)和(5)制得的浓缩液混合制丸;
(7)、将步骤(6)制得的丸剂包裹外衣,缓慢溶解以便于释放药物;
(8)、将步骤(7)制得的丸剂外衣安置丝线,留在阴道外用于拉出残余药物丸剂。
步骤(3)所述的消毒灭菌采用的方法为紫外线照射消毒;
步骤(6)所述的制丸采用的方法为水丸泛制法或者塑制丸法,还可添加辅料,确保丸剂强度,不易散烂;
步骤(2)中制粉的细度为100~200目;
步骤(8)中丝线长度为20~40cm,采用蚕丝或尼龙软线,采用压制、绑扎、粘贴等方式固定在丸剂上,灭菌后包装。
水剂制备包括下述步骤:
(1)、称取各原料;
(2)、将步骤(1)称取的青黛、白矾、滑石粉分别与水混合分散,放置备用;
(3)、将步骤(1)称取的冰片加入薄荷脑混合,制得混合液;
(4)、将步骤(1)称取的甘草、黄柏、金银花、连翘碎断,碎断的长度为5~10mm,用水提取,用水提取的温度为60~90度,制得提取液,再将提取液浓缩至含生药1~2g/ml,放置备用;
(5)、将步骤(2)、(3)、(4)制得的液体混合,制得混合液;
(6)、将步骤(5)制得的混合液加水配置成含生药0.1~1g/ml,即得所述的水剂。
本发明对妇科热毒燥湿有独特的效果,不仅具有杀菌灭菌的效果,能从病因上控制炎症,还能有效解毒、燥湿,并且具有润泽和紧致阴道的功效。
冰片味辛、苦,微寒,清香宣散,具有开窍醒神、治疗疮痈疳痔的作用,具有润泽阴道,增强舒适感的作用,所选用的冰片为艾片(左旋龙脑),为菊科植物艾纳香Blumea balsami fera(L.)DC.的新鲜茎叶经提取加工制成的结晶,更易被吸收并且无毒。
青黛具有清热解毒,凉血消斑,泻火定惊的作用,用于温毒发斑,血热吐衄,胸痛咳血, 口疮,痄腮,喉痹,小儿惊痫,对于妇科炎症伴随的内毒燥热有效果。
滑石粉选用医药-食品级滑石粉,为天然水合硅酸镁,亲水性物质,白至灰白色结晶粉,不溶于水、冷酸及碱液,为药物制剂中应用较广泛的润滑剂兼助流抗粘剂,其化学性质稳定,无毒、副作用,用于此发明作用在于混合原料时起到抗粘作用,同时起到润滑阴道作用。
发明中选用的白矾,为矿物明矾石经加工提炼而成的结晶,主要化学成分为十二水合硫酸铝钾,外用能解毒杀虫,燥湿止痒,对带下阴痒、白带过多有很好的效果,同时具有收敛作用,对子宫下垂、阴道松弛有紧致作用。
甘草用于痈疽疮疡、咽喉肿痛等。可单用,内服或外敷,或配伍应用。痈疽疮疡,常与金银花、连翘等同用,共奏清热解毒之功,如仙方活命饮。
黄柏性味:苦、寒,具有清热解毒、清热燥湿的功效,主治湿热痢疾、泄泻、黄疸,梦遗、淋浊、带下,骨蒸劳热,盗汗;以及口舌生疮,目赤肿痛,痈疽疮毒,皮肤湿疹。
金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疗疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效,常与连翘同用,具有清热解毒、疏风解表作用。
连翘性味:苦,凉,具有清热,解毒,散结,消肿的功能,主治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭,还能止痛,通月经。
本发明对于妇科炎症,从源头上能杀菌抗虫,白矾具有广泛的杀菌作用;甘草、金银花、连翘则具有清热解毒,疏风解表的作用;冰片具有独特的止痛止痒的作用,且具有清香能去除异味;白矾和连翘还具有止血的作用;连翘还对经血闭合不畅有很好作用;黄柏具有清热解毒、的功效,对带下病有独特功效。
本发明具有杀菌抗虫、清热解毒、清热敛湿、止痛止痒、去除异味、止血通经的作用,对妇科疾病具有清热敛湿的效果,并且还能起到润泽紧致阴道的保健作用。
具体实施方式
以下结合实施例对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。
实施例1
原料重量份:冰片2份,青黛5份,滑石粉7份,白矾7份,甘草7份,黄柏12份,金银花10份,连翘10份;
所述的冰片为菊科植物艾纳香的新鲜茎叶经提取加工制成的结晶。
所述的青黛、甘草、黄柏、金银花、连翘为干燥的药材;
丸剂制备:
(1)、称取各原料;
(2)、将步骤(1)称取的冰片、青黛、滑石粉、白矾、甘草制粉,制粉的细度为200目;
(3)、将步骤(2)制得的粉进行紫外线照射消毒灭菌,放置备用;
(4)、将步骤(1)称取的黄柏、金银花、连翘碎断,碎断的长度为5mm,用酒精提取,制得提取液,再将提取液浓缩至含生药2g/ml;
(5)、将步骤(4)产生的药渣用水提取,用水提取的温度为90度,制得提取液,再将提取液浓缩至含生药2g/ml;
(6)、将步骤(3)制得的粉剂与步骤(4)和(5)制得的浓缩液采用水丸泛制法混合制丸;
(7)、将步骤(6)制得的丸剂包裹外衣;
(8)、将步骤(7)制得的丸剂外衣安置丝线,留线长度为20cm。
实施例2
原料准备与实施例1相同,然后制备水剂。
水剂制备包括下述步骤:
(1)、称取各原料;
(2)、将步骤(1)称取的青黛、白矾、滑石粉分别与水混合分散,放置备用;
(3)、将步骤(1)称取的冰片加入薄荷脑混合,制得混合液;
(4)、将步骤(1)称取的甘草、黄柏、金银花、连翘碎断,碎断的长度为10mm,用水提取,用水提取的温度为80度,制得提取液,再将提取液浓缩至含生药1g/ml,放置备用;
(5)、将步骤(2)、(3)、(4)制得的液体混合,制得混合液;
(6)、将步骤(5)制得的混合液加水配置成含生药1g/ml,即得所述的水剂。
实施例3
原料重量份:冰片1份,青黛4份,滑石粉10份,白矾10份,甘草5份,黄柏10份,金银花12份,连翘12份;
所述的冰片为菊科植物艾纳香的新鲜茎叶经提取加工制成的结晶。
所述的青黛、甘草、黄柏、金银花、连翘为干燥的药材;
丸剂制备:
(1)、称取各原料;
(2)、将步骤(1)称取的冰片、青黛、滑石粉、白矾、甘草制粉,制粉的细度为150目;
(3)、将步骤(2)制得的粉进行紫外线照射消毒灭菌,放置备用;
(4)、将步骤(1)称取的黄柏、金银花、连翘碎断,碎断的长度为7mm,用酒精提取,制得提取液,再将提取液浓缩至含生药1g/ml;
(5)、将步骤(4)产生的药渣用水提取,用水提取的温度为90度,制得提取液,再将提取液浓缩至含生药2g/ml;
(6)、将步骤(3)制得的粉剂与步骤(4)和(5)制得的浓缩液采用水丸泛制法混合制丸;
(7)、将步骤(6)制得的丸剂包裹外衣;
(8)、将步骤(7)制得的丸剂外衣安置丝线,留线长度为25cm。
实施例4
原料准备与实施例3相同,然后制备水剂。
水剂制备包括下述步骤:
(1)、称取各原料;
(2)、将步骤(1)称取的青黛、白矾、滑石粉分别与水混合分散,放置备用;
(3)、将步骤(1)称取的冰片加入薄荷脑混合,制得混合液;
(4)、将步骤(1)称取的甘草、黄柏、金银花、连翘碎断,碎断的长度为6mm,用水提取,用水提取的温度为60度,制得提取液,再将提取液浓缩至含生药1.5g/ml,放置备用;
(5)、将步骤(2)、(3)、(4)制得的液体混合,制得混合液;
(6)、将步骤(5)制得的混合液加水配置成含生药0.6g/ml,即得所述的水剂。
Claims (10)
1.应用于妇科的解毒敛湿的药物,其特征在于,由下述重量比的原料制成:冰片0.1~4份,青黛0.2~10份,滑石粉1~15份,白矾0.3~15份,甘草1~17份,黄柏2~20份,金银花5~15份,连翘2~17份。
2.根据权利要求1所述的药物,其特征在于,由下述重量比的原料制成:冰片1~3份,青黛3~7份,滑石粉5~10份,白矾1~10份,甘草5~12份,黄柏10~13份,金银花7~12份,连翘7~12份。
3.根据权利要求1所述的药物,其特征在于,所述的冰片为菊科植物艾纳香的新鲜茎叶经提取加工制成的结晶。
4.根据权利要求1所述的药物,其特征在于,所述的青黛、甘草、黄柏、金银花、连翘为干燥的药材。
5.根据权利要求1、2、3或4所述的药物的制备方法,其特征在于,丸剂的制备包括下述步骤:
(1)、称取各原料;
(2)、将步骤(1)称取的冰片、青黛、滑石粉、白矾、甘草制粉;
(3)、将步骤(2)制得的粉消毒灭菌,放置备用;
(4)、将步骤(1)称取的黄柏、金银花、连翘碎断,用酒精提取,制得提取液,再将提取液浓缩至含生药1~2g/ml;
(5)、将步骤(4)产生的药渣用水提取,制得提取液,再将提取液浓缩至含生药1~2g/ml;
(6)、将步骤(3)制得的粉剂与步骤(4)和(5)制得的浓缩液混合制丸;
(7)、将步骤(6)制得的丸剂包裹外衣;
(8)、将步骤(7)制得的丸剂外衣安置丝线。
6.根据权利要求1、2、3或4所述的药物的制备方法,其特征在于,水剂制备包括下述步骤:
(1)、称取各原料;
(2)、将步骤(1)称取的青黛、白矾、滑石粉分别与水混合分散,放置备用;
(3)、将步骤(1)称取的冰片加入薄荷脑混合,制得混合液;
(4)、将步骤(1)称取的甘草、黄柏、金银花、连翘碎断,用水提取,制得提取液,再将提取液浓缩至含生药1~2g/ml,放置备用;
(5)、将步骤(2)、(3)、(4)制得的液体混合,制得混合液;
(6)、将步骤(5)制得的混合液加水配置成含生药0.1~1g/ml,即得所述的水剂。
7.根据权利要求5所述的制备方法,其特征在于,步骤(3)所述的消毒灭菌采用的方法为紫外线照射消毒。
8.根据权利要求5所述的制备方法,其特征在于,步骤(6)所述的制丸采用的方法为水丸泛制法或者塑制丸法。
9.根据权利要求5所述的制备方法,其特征在于,步骤(2)中制粉的细度为100~200目。
10.根据权利要求5或6所述的制备方法,其特征在于,所述碎断的长度为5~10mm;所述用水提取的温度为60~90度。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610320957.3A CN105998299A (zh) | 2016-05-16 | 2016-05-16 | 应用于妇科的解毒敛湿的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610320957.3A CN105998299A (zh) | 2016-05-16 | 2016-05-16 | 应用于妇科的解毒敛湿的药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105998299A true CN105998299A (zh) | 2016-10-12 |
Family
ID=57098230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610320957.3A Pending CN105998299A (zh) | 2016-05-16 | 2016-05-16 | 应用于妇科的解毒敛湿的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105998299A (zh) |
-
2016
- 2016-05-16 CN CN201610320957.3A patent/CN105998299A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102160887B (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
CN102697961B (zh) | 一种治疗阴道炎的妇科清洗液及其制作方法 | |
CN102895163B (zh) | 一种绿色天然爽身粉 | |
CN102309716A (zh) | 一种治疗带下症的中药组合物及其制备方法 | |
CN103494958B (zh) | 一种治疗妇科炎症的中药洗液及制备方法 | |
KR20210119188A (ko) | 여성 외음부 세정제 및 그 제조방법 | |
CN104274741A (zh) | 一种治疗妇科病的药物组合物及药用卫生巾 | |
CN101461916B (zh) | 一种治疗妇科疾病的外用中药组合物及其制配方法 | |
CN105727209A (zh) | 一种用于产后护理的中药组合物 | |
CN103071096B (zh) | 用于治疗老年性阴道炎的外用制剂及其制备方法 | |
CN105998966A (zh) | 缓解阴肿阴痒的药物及其制备方法 | |
CN105920462A (zh) | 作用于阴道的消炎止痛的药物及其制备方法 | |
CN110393768A (zh) | 一种母猪子宫消炎的组合中药灌注药物及其制备方法和应用 | |
CN105998299A (zh) | 应用于妇科的解毒敛湿的药物及其制备方法 | |
CN100431597C (zh) | 一种治疗慢性盆腔炎的中药制剂 | |
CN105943978A (zh) | 一种用于妇科炎症的药物及其制备方法 | |
CN105920116A (zh) | 针对经血不畅的药物及其制备方法 | |
CN111743982A (zh) | 一种外阴洗液及其制备方法 | |
CN108853410A (zh) | 一种用于防治妇科疾病的中药药剂及其制备方法和应用 | |
CN105920088A (zh) | 用于妇科滴虫性炎症的药物及其制备方法 | |
CN105998129A (zh) | 应用于妇科的祛腐生肌的药物及其制备方法 | |
CN104274617A (zh) | 一种护理治疗急性宫颈炎的中药组合物 | |
CN112294922A (zh) | 一种治疗阴道炎的中草药物及其制作方法 | |
CN103768472A (zh) | 一种用于治疗妇科疾病的栓剂及其生产方法 | |
CN103720749A (zh) | 一种治疗阴道炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161012 |